MwanzoZYDUSLIFE • NSE
add
Zydus Lifesciences Ltd
Bei iliyotangulia
₹ 974.55
Bei za siku
₹ 973.30 - ₹ 987.45
Bei za mwaka
₹ 630.00 - ₹ 1,324.30
Thamani ya kampuni katika soko
986.31B INR
Wastani wa hisa zilizouzwa
elfu 988.29
Uwiano wa bei na mapato
22.98
Mgao wa faida
0.31%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 52.37B | 19.87% |
Matumizi ya uendeshaji wa biashara | 25.83B | 28.18% |
Mapato halisi | 9.11B | 13.80% |
Kiwango cha faida halisi | 17.40 | -5.07% |
Mapato kwa kila hisa | 9.05 | 14.27% |
EBITDA | 14.07B | 32.51% |
Asilimia ya kodi ya mapato | 28.86% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 24.95B | 64.20% |
Jumla ya mali | 314.46B | 21.51% |
Jumla ya dhima | 72.91B | 47.64% |
Jumla ya hisa | 241.55B | — |
hisa zilizosalia | 1.01B | — |
Uwiano wa bei na thamani | 4.49 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 12.51% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 9.11B | 13.80% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacturing of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020. Wikipedia
Ilianzishwa
1952
Tovuti
Wafanyakazi
26,921
